Fred R. Hirsch

Fluorescence versus white-light bronchoscopy for detection of preneoplastic lesions: a randomized study.

Y. Miller, F. Hirsch, P. Bunn, 2001, Journal of the National Cancer Institute.

Expression of Her-2/neu in human lung cancer cell lines by immunohistochemistry and fluorescence in situ hybridization and its relationship to in vitro cytotoxicity by trastuzumab and chemotherapeutic agents.

F. Hirsch, P. Bunn, W. Franklin, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

MET phosphorylation predicts poor outcome in small cell lung carcinoma and its inhibition blocks HGF-induced effects in MET mutant cell lines

S. Serrano, M. Salido, F. Hirsch, 2011, British Journal of Cancer.

Finding ALK-positive lung cancer: what are we really looking for?

F. Hirsch, W. Franklin, M. Varella‐Garcia, 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Small Cell Lung Cancer: Can Recent Advances in Biology and Molecular Biology Be Translated into Improved Outcomes?

M. Krasnow, J. Minna, P. Massion, 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Evaluation of HER-2/neu gene amplification and protein expression in non-small cell lung carcinomas

F. Hirsch, P. Bunn, W. Franklin, 2002, British Journal of Cancer.

HER3 genomic gain and sensitivity to gefitinib in advanced non-small-cell lung cancer patients

F. Cappuzzo, F. Hirsch, P. Bunn, 2005, British Journal of Cancer.

KRAS Mutations and Susceptibility to Cetuximab and Panitumumab in Colorectal Cancer

A. Jimeno, W. Messersmith, Fred R. Hirsch, 2009, Cancer journal.

Third CECOG consensus on the systemic treatment of non-small-cell lung cancer.

C. Gridelli, R. Pirker, T. Ciuleanu, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

versus a

L. Bazhenova, P. Mack, M. Redman, 2017 .

βV-tubulin expression is associated with outcome following taxane-based chemotherapy in non-small cell lung cancer

M. Engelhard, F. Hirsch, T. Gauler, 2012, British Journal of Cancer.